Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Akcea Therapeutics Inc. (AKCA)

22.46   -0.01 (-0.04%) 09-20 16:00
Open: 22.37 Pre. Close: 22.47
High: 22.7694 Low: 21.74
Volume: 156,455 Market Cap: 2090M
Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 22.799 - 22.91 22.91 - 23.019
Low: 21.42 - 21.557 21.557 - 21.691
Close: 22.201 - 22.423 22.423 - 22.641

Technical analysis

as of: 2019-09-20 4:22:27 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 26.59     One year: 31.06
Support: Support1: 20.24    Support2: 18.68
Resistance: Resistance1: 22.77    Resistance2: 26.59
Pivot: 21.17
Moving Average: MA(5): 22.24     MA(20): 21.06
MA(100): 22.16     MA(250): 26.15
MACD: MACD(12,26): 0.22     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 90.31     %D(3): 89.32
RSI: RSI(14): 56.99
52-week: High: 37.73  Low: 18.68  Change(%): -19.7
Average Vol(K): 3-Month: 18159  10-Days: 16260

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AKCA has closed below upper band by 18.4%. Bollinger Bands are 7.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 93.03
Shares Float (M) 16.35
% Held by Insiders 85.58
% Held by Institutions 26.38
Shares Short (K) 6710
Shares Short P. Month (K)

Stock Financials

EPS -1.690
Book Value (p.s.) 3.970
PEG Ratio -0.20
Profit Margin -65.62
Operating Margin -67.04
Return on Assets (ttm) -22.2
Return on Equity (ttm) -43.8
Qtrly Rev. Growth 45.3
Gross Profit (p.s.) -0.795
Sales Per Share
EBITDA (p.s.) -1.516
Qtrly Earnings Growth
Operating Cash Flow (M) -81.75
Levered Free Cash Flow (M) -102.22

Stock Valuations

P/E -13.29
P/E Growth Ratio
P/BV 5.66
P/S 856333504.00
P/CF -25.56

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.